People · Operator

Russell Cann

Named in public records as an officer, director or promoter · active 2018–2018 · Other Technology

1
Companies
3
Filings
$252.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Core Scientific, Inc.Other TechnologySeries D+$252.0M$7.9B2018
Operator network

Russell Cann at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Bryce Johnson · 5 companies · 1 sharedBryce JohnsonAber Whitcomb · 4 companies · 1 sharedAber WhitcombDarin Feinstein · 4 companies · 1 sharedDarin FeinsteinKevin Turner · 4 companies · 1 sharedKevin TurnerMichael Levitt · 3 companies · 1 sharedMichael LevittMatthew Bishop · 2 companies · 1 sharedMatthew BishopMitch Edwards · 2 companies · 1 sharedMitch EdwardsAndrew Yeung · 1 companies · 1 sharedAndrew YeungCharlie Basil · 1 companies · 1 sharedCharlie BasilJim Benedetto · 1 companies · 1 sharedJim BenedettoJim Cleveland · 1 companies · 1 sharedJim ClevelandMatthew Minnis · 1 companies · 1 sharedMatthew MinnisNick Phillips · 1 companies · 1 sharedNick PhillipsSharon Orlopp · 1 companies · 1 sharedSharon OrloppWeston Adams · 1 companies · 1 sharedWeston AdamsCore Scientific, Inc. · $252.0M raisedCore Scientific, Inc.Russell CannRC
Russell Cann Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Russell Cann on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Bryce Johnson15
Kevin Turner14
Aber Whitcomb14
Darin Feinstein14
Michael Levitt13
Mitch Edwards12
Matthew Bishop12
Weston Adams11
Jim Benedetto11
Sharon Orlopp11
Jim Cleveland11
Andrew Yeung11
Charlie Basil11
Nick Phillips11
Matthew Minnis11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.